[The gastrointestinal tract microbiom in connective tissue diseases]

Area of Science:

• Microbiome research
• Autoimmune disease pathogenesis
• Connective tissue diseases

Background:

• Autoimmune disorders may be influenced by genetics, environment, infections, and the human body microbiota, particularly the gastrointestinal tract microbiota.
• Emerging evidence links gastrointestinal tract dysbiosis, specifically gut dysbiosis, with connective tissue diseases.
• It remains uncertain if microbiome alterations are a cause or effect of autoimmune disease.

Purpose of the Study:

• To review current data on the role of the gastrointestinal tract microbiome in connective tissue diseases.
• To explore the complex relationship between gut dysbiosis and autoimmune conditions.
• To highlight the need for further research into microbiome's contribution to disease susceptibility and pathogenesis.

Main Methods:

• Literature review of existing studies on gastrointestinal microbiome and connective tissue diseases.
• Analysis of current evidence linking gut dysbiosis to autoimmune conditions.
• Synthesis of data regarding the role of microbial diversity in disease development.

Main Results:

• The gastrointestinal tract microbiome, including gut dysbiosis, is increasingly associated with connective tissue diseases.
• Defining a 'normal' or 'favorable' microbiome is challenging due to microbial variability.
• The exact role of microbiome alterations in the pathogenesis and clinical manifestations of connective tissue diseases requires further investigation.

Conclusions:

• Further research is essential to understand how the human microbiome impacts disease susceptibility.
• Characterizing the role of microbial diversity is crucial for understanding connective tissue disease pathogenesis.
• Identifying specific dysbiosis patterns could lead to personalized patient management strategies.